A Phase I/II Study to Evaluate the Safety, Tolerability and Efficacy of PerioSept and Scaling and Root Planing in Subjects With Periodontitis
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Taurolidine (Primary)
- Indications Periodontitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Geistlich
- 18 Jan 2018 Planned End Date changed from 1 Feb 2018 to 1 Dec 2018.
- 18 Jan 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 18 Jan 2018 Status changed from recruiting to active, no longer recruiting.